{"AllianceGenome": "602", "HGNC": "602", "MIM": "107690", "_id": "337", "_version": 1, "accession": {"genomic": ["AP006216.1", "AY422950.1", "AY555191.1", "CH471065.1", "CP068267.2", "EU429935.1", "J02758.1", "M14642.1", "NC_000011.10", "NC_060935.1", "NG_012044.1"], "protein": ["AAA51744.1", "AAA51745.1", "AAA51748.1", "AAA96731.1", "AAB59516.1", "AAH74764.1", "AAI13595.1", "AAI13597.1", "AAQ91809.1", "AAS68228.1", "CAA31955.1", "EAW67271.1", "NP_000473.2", "P06727.4"], "rna": ["AL531739.3", "BC074764.2", "BC113594.1", "BC113596.1", "M10373.1", "M13654.1", "M14566.1", "NM_000482.4", "X13629.1"], "translation": [{"protein": "AAI13597.1", "rna": "BC113596.1"}, {"protein": "AAA51748.1", "rna": "M14566.1"}, {"protein": "NP_000473.2", "rna": "NM_000482.4"}, {"protein": "AAI13595.1", "rna": "BC113594.1"}, {"protein": "AAH74764.1", "rna": "BC074764.2"}, {"protein": "AAB59516.1", "rna": "M10373.1"}, {"protein": "CAA31955.1", "rna": "X13629.1"}, {"protein": "AAA51744.1", "rna": "M13654.1"}]}, "ensembl": {"gene": "ENSG00000110244", "protein": "ENSP00000350425", "transcript": "ENST00000357780", "translation": [{"protein": "ENSP00000350425", "rna": "ENST00000357780"}], "type_of_gene": "protein_coding"}, "entrezgene": "337", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 10.57165568, "exp_mis": 167.6061103, "exp_syn": 86.273446, "lof_z": 0.783485596047502, "mis_z": -1.14830692349269, "mu_lof": 8.22082583963e-07, "mu_mis": 1.468188329e-05, "mu_syn": 7.5034945163e-06, "n_lof": 8.0, "n_mis": 198.0, "n_syn": 78.0, "p_li": 3.57595118139907e-05, "p_null": 0.407788803554467, "p_rec": 0.592175436933719, "syn_z": 0.552201433876207}, "bp": 1191, "cds_end": 116693907, "cds_start": 116691582, "n_exons": 3, "nonpsych": {"exp_lof": 9.5064619, "exp_mis": 151.6378015, "exp_syn": 78.0238891, "lof_z": 0.479844641917563, "mis_z": -1.03883089157705, "mu_lof": 8.22082583963e-07, "mu_mis": 1.468188329e-05, "mu_syn": 7.5034945163e-06, "n_lof": 8.0, "n_mis": 177.0, "n_syn": 72.0, "p_li": 2.0874169205319e-05, "p_null": 0.550454174819924, "p_rec": 0.449524951010871, "syn_z": 0.429365081271244}, "nontcga": {"exp_lof": 9.71988948, "exp_mis": 154.1915988, "exp_syn": 79.36554145, "lof_z": 0.544190724386736, "mis_z": -1.31632924855353, "mu_lof": 8.22082583963e-07, "mu_mis": 1.468188329e-05, "mu_syn": 7.5034945163e-06, "n_lof": 8.0, "n_mis": 187.0, "n_syn": 76.0, "p_li": 2.25969622756801e-05, "p_null": 0.505942652386654, "p_rec": 0.494034750651071, "syn_z": 0.239199939469438}, "transcript": "ENST00000357780.3"}, "exons": [{"cdsend": 116823191, "cdsstart": 116820866, "chr": "11", "position": [[116820699, 116821881], [116822658, 116822785], [116823142, 116823304]], "strand": -1, "transcript": "NM_000482", "txend": 116823304, "txstart": 116820699}], "exons_hg19": [{"cdsend": 116693907, "cdsstart": 116691582, "chr": "11", "position": [[116691415, 116692597], [116693374, 116693501], [116693858, 116694020]], "strand": -1, "transcript": "NM_000482", "txend": 116694020, "txstart": 116691415}], "generif": [{"pubmed": 11108737, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 11181750, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11472750, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11583715, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11592042, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 11841825, "text": "Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins"}, {"pubmed": 11940599, "text": "Interfacial exclusion pressure determines the ability of apolipoprotein A-IV truncation mutants to activate cholesterol ester transfer protein"}, {"pubmed": 11941585, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11952809, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 12082592, "text": "Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 12116231, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12121350, "text": "Association of apolipoprotein A-IV genotype with blood glucose, plasma lipoprotein levels, total cholesterol, and triglycerides in a gender-specific manner"}, {"pubmed": 12121350, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12220435, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12417525, "text": "Association between APOA4 and triglycerides (TG) reflects linkage disequilibrium with known TG-raising sites."}, {"pubmed": 12417525, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12495081, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12556235, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12664082, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 12676816, "text": "Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels."}, {"pubmed": 12676816, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12691171, "text": "Clinical trial of gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 12697303, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12777472, "text": "No major differences exist in the apoA-IV plasma distribution pattern between coronary artery disease patients and controls; therefore, the antiatherogenic effect of apoA-IV has to be explained by other functional properties of apoA-IV"}, {"pubmed": 12860258, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12962772, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14751811, "text": "H-apoA-IV expression in apoE(0) mice reduces atherogenesis & decreases proinflammatory cytokine secretion after LPS administration.  h-apoA-IV exerts its protective role by specifically, but partially, inhibiting LPS-induced stimulation of monocytes."}, {"pubmed": 15175360, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15252864, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 15254593, "text": "Results provide the first direct support for the hypothesis that apolipoprotein A-IV is an endogenous anti-inflammatory protein."}, {"pubmed": 15258202, "text": "apoA-IV may physically interact with apoB in the secretory pathway and affects intracellular distribution of apoB"}, {"pubmed": 15304365, "text": "Human apoA-I/C-III/A-IV transgenic rabbits may provide a reliable model for studies of the transcriptional regulation of the cluster, and for evaluating the effects of different agents on the expression of the three genes."}, {"pubmed": 15311933, "text": "the amphipathic alpha helices in apoA4 form a large domain that may be similar to the N-terminal helical bundle domains of apoA1 and apoE but apoA4 lacks the C-terminal lipid-binding and cholesterol efflux-promoting domain of these apolipoproteins"}, {"pubmed": 15359534, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15488874, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15559160, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15649902, "text": "the apoCIII enhancer regulates expression of apoAI, apo-CIII, and apoAIV but not apoAV in vivo; the entire cluster has roles in regulating lipid metabolism"}, {"pubmed": 15721024, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15721024, "text": "the apo A-IV-2 allele is associated with a modest reduction in plasma triglyceride levels in the general population"}, {"pubmed": 15764642, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15806598, "text": "A significant association between the presence of apolipoprotein A-IV His allele and cerebrovascular disease, obesity and depression."}, {"pubmed": 15806598, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15823278, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15864114, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15868628, "text": "Observational study of gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 15910632, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 15928313, "text": "HNF-4alpha and gamma functionally interact with a second hormone-responsive element present in the proximal region of the human apoA-IV promoter."}, {"pubmed": 15962178, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 16030523, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16105043, "text": "ApoA-IV immunostaining was detected in proximal and distal tubular cells, capillaries and blood vessels but not inside glomeruli"}, {"pubmed": 16120654, "text": "novel role for Apo A-IV in the regulation of intracellular glutathione redox balance and the modulation of redox-dependent apoptosis via stimulation of G6PD activity"}, {"pubmed": 16159879, "text": "the C-terminal sequence can modulate the conformation and lipid affinity of apoA-IV"}, {"pubmed": 16321685, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16326171, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 16326171, "text": "While female carriers of the APOA4(347) S allele had lower TG concentrations than those with the common T/T allele, males with the S allele had higher concentrations."}, {"pubmed": 16338932, "text": "E-cadherin controls enterocyte-specific expression of genes, such as the apoA-IV gene, through the control of hepatic nuclear factor 4alpha nuclear abundance"}, {"pubmed": 16602826, "text": "Because modulation of lipoproteins is also seen in genetically altered longevity models, it may be a common pathway influencing lifespan from nematodes to humans"}, {"pubmed": 16651467, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16710093, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16763159, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16770585, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 16770585, "text": "Potential interactions between APOA4 genotypes and metabolic/oxidative stress components of the diabetic milieu leading to rapid progression of atherosclerosis."}, {"pubmed": 16781717, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16781717, "text": "the variability in APOA1/C3/A4/A5 gene cluster may affect TG and HDL levels in women with type 2 diabetes"}, {"pubmed": 16788210, "text": "Data demonstrate that the increase of apoA-IV caused by renal impairment is significantly modulated by low levels of serum albumin as a measure for the severity of the nephrotic syndrome."}, {"pubmed": 16929032, "text": "the induction of apoA-IV expression in fasting and diabetes likely involves PGC-1 alpha-mediated coactivation of HNF-4 alpha in addition to glucocorticoid-dependent actions"}, {"pubmed": 16945374, "text": "apoA-IV can bind to LDL & acts as a site-specific antioxidant. reduced inhibition of LDL oxidation by apoA-IV-S347 compared to wild type apoA-IV may account for previous association of the APOA4 S347 variant with increased CHD risk & oxidative stress."}, {"pubmed": 17130180, "text": "Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17206692, "text": "ApoA-IV polymorphism is not associated with either disease activity or apoA-IV plasma levels in patients with Crohn's disease or ulcerative colitis."}, {"pubmed": 17261136, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17378725, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17378725, "text": "Variants may play an important role in the individual sensitivity of lipid parameters to dietary composition in men."}, {"pubmed": 17457002, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17654446, "text": "Polymorphisms in ApoAI-CIII-AIV gene cluster are associated with risks of diabetes and coronary heart disease."}, {"pubmed": 17712726, "text": "ApoA-IV expression is significantly impaired in inflammatory bowel diseases mucosa, even in non-inflamed regions."}, {"pubmed": 17825930, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 17825930, "text": "genetic variation of 3' flanking region of ApoA-I (PstI), 3' untranslated region of ApoC-III (SstI) and intron 2 of ApoA-IV (XbaI) in 193 angiographically diagnosed coronary heart disease Punjab patients"}, {"pubmed": 17855807, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17964293, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18193043, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18430727, "text": "lipid-free apoA-IV exists as a complex helical bundle with the N and C termini in close proximity"}, {"pubmed": 18513389, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18636124, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18664021, "text": "Codon 9, Msp I and VNTR polymorphisms in the apo A-IV gene are associated with type-IV hyperlipoproteinaemia in a Chinese population."}, {"pubmed": 18664021, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18678879, "text": "the apoCIII enhancer contributes to the maintenance of an active chromatin subdomain of the apoAI/CIII/AIV genes, but not apoAV"}, {"pubmed": 18789138, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18948973, "text": "Blood levels increase after gastric bypass in morbid obesity, which may contribute to weight loss as well as the improvements in inflammation and cardiovascular disease."}, {"pubmed": 18996102, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19057464, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19131662, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19166692, "text": "Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19263529, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19336370, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19336475, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19336561, "text": "Reduced apolipoprotein A-IV expression is associated with ovarian cancer."}, {"pubmed": 19403283, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19433068, "text": "results indicate that human apoA-IV is regulated directly by PPARalphavia the -2979/-2967 PPRE"}, {"pubmed": 19592705, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19592705, "text": "We have identified new associations between SNPs in the APOA1/C3/A4/A5 gene cluster and altered postprandial lipid metabolism."}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19689828, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19701693, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19732897, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19732897, "text": "polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster may have roles in familial combined hyperlipidaemia in Hong Kong Chinese"}, {"pubmed": 19878569, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19948975, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and genetic testing. (HuGE Navigator)"}, {"pubmed": 20031551, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20117098, "text": "The two common aminoacid substitutions,T347S and Q360H , have no effect on the ability of apoA-IV to maintain endothelial homeostasis."}, {"pubmed": 20164363, "text": "Clinical trial of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20164363, "text": "This study supports the concept that single nucleotide polymorphisms in APOA1and APOA4 genes influences atherogenic characteristics of low density lipoprotein particles in response to diet."}, {"pubmed": 20430392, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20554794, "text": "Data establish that the T347S substitution alters the conformation of apolipoprotein A-IV and lowers its interfacial activity-changes that could account for the effect of this polymorphism on postprandial lipid metabolism."}, {"pubmed": 20602615, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20609189, "text": "serum apo A-IV level was independently associated with creatinine, the neutrophil/ lymphocyte ratio, and maximum carotid intima media thickness; Serum apo A-IV is associated with atherosclerotic lesions in hemodialysis patients"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20674306, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20674306, "text": "single nucleotide polymorphisms in apolipoproteins A-I, C3, A4, and A5, as modulated by dietary fat intake, appear to influence allostatic load parameters in Puerto Ricans"}, {"pubmed": 20714348, "text": "Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20810159, "text": "a candidate target molecule for the treatment of seasonal allergic rhinitis"}, {"pubmed": 21127258, "text": "MTTP is regulated by apo A-IV in manner to promote increased packaging of triglyceride into chylomicron core, which may be important in neonatal fat absorption."}, {"pubmed": 21297956, "text": "increased CSF prothrombin, Apo A-IV, and haptoglobin may be involved in pathogenesis of HD and may serve as potential biomarkers for HD."}, {"pubmed": 21324458, "text": "APOA4 (rs675) was associated with triglyceride response in non-metabolic syndrome subjects."}, {"pubmed": 21407247, "text": "Significant decreases (at least P<0.05) were observed in sICAM concentrations in PON-1 55LM+MM, PON-1 QQ192 and APOA4-2 carriers while decreases in sVCAM in QR+RR and APOA4-1 carriers were observed."}, {"pubmed": 21712729, "text": "the APOA4 360His allele might be a risk factor for depression and unfavorable lipid profile and depression for elderly people in the Brazilian population"}, {"pubmed": 21767760, "text": "the ApoAI-CIII-AIV SacI polymorphism was associated with MI in Tunisian patients."}, {"pubmed": 23096082, "text": "APOA4 S347 allele predisposes to obesity and high waist circumference in Turkish postmenopausal women."}, {"pubmed": 23132909, "text": "a novel function of apoA-IV in the biogenesis of discrete HDL-A-IV particles with the participation of ABCA1 and LCAT"}, {"pubmed": 23288849, "text": "Small-angle X-ray scattering of apolipoprotein A-IV reveals the importance of its termini for structural stability"}, {"pubmed": 23338533, "text": "apoA-IV was increased in follicular fluid from polycystic ovary syndrome patients compared with those from normal controls"}, {"pubmed": 24211975, "text": "human apolipoproteina4 and apolipoproteinc3 genes are suppressed by phorbol myristate acetate in hepatic and intestinal cells"}, {"pubmed": 24311788, "text": "apoA-IV inhibits hepatic gluconeogenesis by decreasing Glc-6-Pase and PEPCK gene expression through NR1D1."}, {"pubmed": 24425874, "text": "The structure of human apolipoprotein A-IV as revealed by stable isotope-assisted cross-linking, molecular dynamics, and small angle x-ray scattering."}, {"pubmed": 24598141, "text": "transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH"}, {"pubmed": 24606699, "text": "Human papillomavirus E5 oncoproteins bind the A4 in endoplasmic reticulum to regulate proliferative ability upon differentiation."}, {"pubmed": 25463085, "text": "analysis of methylation patterns of the APOA1/C3/A4/A5 cluster that may be directly involved in the transcriptional regulation of this cluster, especially in liver"}, {"pubmed": 25733664, "text": "the systematic conversion of conserved prolines to alanine increased the thermodynamic stability of apoA-IV and its propensity to oligomerize"}, {"pubmed": 26397108, "text": "Single nucleotide polymorphisms (Rs7396835) of APOA4 protein did not increase the risk of CHD in the Chinese population."}, {"pubmed": 26485402, "text": "the present findings reveal that High-altitude polycythemia -induced gastric mucosal lesion inspires the protection responses by up-regulating APOA4 and APOC3, and down-regulating GIF."}, {"pubmed": 26491253, "text": "Low levels of APOA1, APOC3, and APOA4 are associated with risk of Alzheimer disease."}, {"pubmed": 26556724, "text": "ApoA-IV colocalizes with NR4A1, which suppresses G6Pase and PEPCK gene expression at the transcriptional level, reducing hepatic glucose output and lowering blood glucose."}, {"pubmed": 27262366, "text": "Renal AApoAIV amyloidosis typically presents with progressive chronic kidney disease and histologically exhibits extensive medullary involvement with sparing of the cortex. The diagnosis is best established by mass spectrometry."}, {"pubmed": 27344311, "text": "Study discovered novel and independent associations of prediabetes and related traits with MASP1, and some evidence for associations with THBS1, GPLD1 and ApoA-IV, suggesting a role for these proteins in the pathophysiology of type 2 diabetes."}, {"pubmed": 27412012, "text": "Analyses of SNP-scores indicate potential causal effects of kidney function and by lesser extent triglycerides on apoA-IV concentrations."}, {"pubmed": 27622441, "text": "The genotype-risk associations were examined between APOA4 (rs5095, rs675, rs5110) and obesity-related phenotypes and other comorbidities in Sucre, Venezuela. There was a higher average waist-hip ratio among rs5095 homozygotes and for conicity index among homozygotes for rs5110."}, {"pubmed": 27870653, "text": "Apolipoprotein L1 and apolipoprotein A-IV and their association with kidney function"}, {"pubmed": 28246167, "text": "These findings indicate that LZIP is a novel modulator of APOA4 expression and hepatic lipid metabolism."}, {"pubmed": 29025558, "text": "APOA-IV glycation is associated with coronary artery disease severity in patients with Type 2 Diabetes Mellitus."}, {"pubmed": 29317355, "text": "The combination of three proteins - apolipoprotein A-IV, complement factor H-related protein 4 and platelet basic protein - demonstrated the best classification performance for our data for diagnosis of growth hormone defic."}, {"pubmed": 30190457, "text": "ApoA-IV inversely correlates with platelet aggregation.ApoA-IV is an endogenous inhibitor of thrombosis. Aspartic acids 5 and 13 at the N-terminus of apoA-IV are required for binding to alphaIIbbeta3 integrin."}, {"pubmed": 31408538, "text": "Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naive allergic patients and allergen-challenged mice."}, {"pubmed": 32388438, "text": "A novel electrochemical immunosensor for the highly sensitive and selective detection of the depression marker human apolipoprotein A4."}, {"pubmed": 32410861, "text": "Advanced Glycated apoA-IV Loses Its Ability to Prevent the LPS-Induced Reduction in Cholesterol Efflux-Related Gene Expression in Macrophages."}, {"pubmed": 32437778, "text": "Identifying functional non-coding variants in APOA5/A4/C3/A1 gene cluster associated with coronary heart disease."}, {"pubmed": 32921312, "text": "Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis."}, {"pubmed": 33130088, "text": "Identification and characterization of a rare variant in apolipoprotein A-IV, p.(V336M), and evaluation of HDL functionality in a Greek cohort with extreme HDL cholesterol levels."}, {"pubmed": 33403595, "text": "Depression Augments Plasma APOA4 without Changes of Plasma Lipids and Glucose in Female Adolescents Carrying G Allele of APOA4 rs5104."}, {"pubmed": 33544467, "text": "Changes in serum levels of Apo AIV in patients with newly diagnosed hyperthyroidism and hypothyroidism: a preliminary study."}, {"pubmed": 33640722, "text": "Decreased serum apolipoprotein A4 as a potential peripheral biomarker for patients with schizophrenia."}, {"pubmed": 34185819, "text": "Novel proteins associated with chronic intermittent hypoxia and obstructive sleep apnea: From rat model to clinical evidence."}, {"pubmed": 34394117, "text": "Apolipoprotein A4 Defines the Villus-Crypt Border in Duodenal Specimens for Celiac Disease Morphometry."}, {"pubmed": 34634315, "text": "Altered HDL proteome predicts incident CVD in chronic kidney disease patients."}, {"pubmed": 36284290, "text": "Serum apolipoprotein A-IV levels are associated with flow-mediated dilation in patients with type 2 diabetes mellitus."}, {"pubmed": 36614113, "text": "Apolipoprotein A-IV Has Bi-Functional Actions in Alcoholic Hepatitis by Regulating Hepatocyte Injury and Immune Cell Infiltration."}, {"pubmed": 36775868, "text": "Apolipoprotein A-IV of diabetic-foot patients upregulates tumor necrosis factor alpha expression in microfluidic arterial models."}, {"pubmed": 37092549, "text": "The distinct metabolism between large and small HDL indicates unique origins of human apolipoprotein A4."}, {"pubmed": 38096951, "text": "Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosis."}, {"pubmed": 38643717, "text": "Apolipoprotein A-IV polymorphisms Q360H and T347S attenuate its endogenous inhibition of thrombosis."}], "genomic_pos": {"chr": "11", "end": 116823304, "ensemblgene": "ENSG00000110244", "start": 116820700, "strand": -1}, "genomic_pos_hg19": {"chr": "11", "end": 116694022, "start": 116691419, "strand": -1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0002227", "pubmed": 15254593, "qualifier": "involved_in", "term": "innate immune response in mucosa"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006869", "pubmed": [1935934, 3095477], "qualifier": "involved_in", "term": "lipid transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006982", "pubmed": 16945374, "qualifier": "involved_in", "term": "response to lipid hydroperoxide"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007159", "pubmed": 15254593, "qualifier": "involved_in", "term": "leukocyte cell-cell adhesion"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0008203", "qualifier": "involved_in", "term": "cholesterol metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008203", "pubmed": 1935934, "qualifier": "involved_in", "term": "cholesterol metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010898", "pubmed": 2307668, "qualifier": "involved_in", "term": "positive regulation of triglyceride catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014012", "qualifier": "involved_in", "term": "peripheral nervous system axon regeneration"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0016042", "pubmed": 3095477, "qualifier": "involved_in", "term": "lipid catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0019430", "pubmed": 16945374, "qualifier": "involved_in", "term": "removal of superoxide radicals"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030300", "qualifier": "involved_in", "term": "regulation of intestinal cholesterol absorption"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032374", "pubmed": 11940599, "qualifier": "involved_in", "term": "regulation of cholesterol transport"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0033344", "qualifier": "involved_in", "term": "cholesterol efflux"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0033344", "pubmed": [1935934, 11162594], "qualifier": "involved_in", "term": "cholesterol efflux"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0033700", "qualifier": "involved_in", "term": "phospholipid efflux"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0033700", "pubmed": 11162594, "qualifier": "involved_in", "term": "phospholipid efflux"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0034014", "qualifier": "involved_in", "term": "response to triglyceride"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:0034371", "pubmed": 2307668, "qualifier": "involved_in", "term": "chylomicron remodeling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034372", "pubmed": 2307668, "qualifier": "involved_in", "term": "very-low-density lipoprotein particle remodeling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034375", "pubmed": 1935934, "qualifier": "involved_in", "term": "high-density lipoprotein particle remodeling"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0034378", "pubmed": 16159879, "qualifier": "involved_in", "term": "chylomicron assembly"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034445", "pubmed": 16945374, "qualifier": "involved_in", "term": "negative regulation of plasma lipoprotein oxidation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035634", "qualifier": "involved_in", "term": "response to stilbenoid"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042157", "qualifier": "involved_in", "term": "lipoprotein metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0042632", "pubmed": 1935934, "qualifier": "involved_in", "term": "cholesterol homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0042744", "pubmed": 16945374, "qualifier": "involved_in", "term": "hydrogen peroxide catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043691", "pubmed": 3095477, "qualifier": "involved_in", "term": "reverse cholesterol transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045723", "pubmed": 2307668, "qualifier": "involved_in", "term": "positive regulation of fatty acid biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0046470", "pubmed": 1935934, "qualifier": "involved_in", "term": "phosphatidylcholine metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0051006", "pubmed": 2307668, "qualifier": "involved_in", "term": "positive regulation of lipoprotein lipase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0055088", "pubmed": 3095477, "qualifier": "involved_in", "term": "lipid homeostasis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0055090", "qualifier": "involved_in", "term": "acylglycerol homeostasis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0065005", "pubmed": 16159879, "qualifier": "involved_in", "term": "protein-lipid complex assembly"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1905920", "pubmed": 1935934, "qualifier": "involved_in", "term": "positive regulation of CoA-transferase activity"}], "CC": [{"evidence": "HDA", "gocategory": "CC", "id": "GO:0005576", "pubmed": 27068509, "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005576", "pubmed": 14718574, "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 20551380, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 1935934, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005769", "qualifier": "located_in", "term": "early endosome"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005788", "qualifier": "located_in", "term": "endoplasmic reticulum lumen"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009986", "pubmed": 1935934, "qualifier": "colocalizes_with", "term": "cell surface"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0034361", "qualifier": "part_of", "term": "very-low-density lipoprotein particle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034361", "pubmed": [3095477, 17154273], "qualifier": "part_of", "term": "very-low-density lipoprotein particle"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0034362", "qualifier": "part_of", "term": "low-density lipoprotein particle"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0034364", "qualifier": "part_of", "term": "high-density lipoprotein particle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034364", "pubmed": 3095477, "qualifier": "part_of", "term": "high-density lipoprotein particle"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0042627", "qualifier": "part_of", "term": "chylomicron"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0042627", "pubmed": 3095477, "qualifier": "part_of", "term": "chylomicron"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0045202", "qualifier": "located_in", "term": "synapse"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0062023", "pubmed": 27559042, "qualifier": "located_in", "term": "collagen-containing extracellular matrix"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 23533145, "qualifier": "located_in", "term": "extracellular exosome"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0072562", "pubmed": 22516433, "qualifier": "located_in", "term": "blood microparticle"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:1903561", "qualifier": "is_active_in", "term": "extracellular vesicle"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0005319", "pubmed": 3080432, "qualifier": "enables", "term": "lipid transporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005507", "pubmed": 16945374, "qualifier": "enables", "term": "copper ion binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [24311788, 32296183, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005543", "qualifier": "enables", "term": "phospholipid binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0008289", "pubmed": 16159879, "qualifier": "enables", "term": "lipid binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016209", "pubmed": 16945374, "qualifier": "enables", "term": "antioxidant activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0031210", "pubmed": [1935934, 11940599], "qualifier": "enables", "term": "phosphatidylcholine binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": 22579246, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042803", "pubmed": 1935934, "qualifier": "enables", "term": "protein homodimerization activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0060228", "qualifier": "enables", "term": "phosphatidylcholine-sterol O-acyltransferase activator activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0060228", "pubmed": 1935934, "qualifier": "enables", "term": "phosphatidylcholine-sterol O-acyltransferase activator activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0120020", "qualifier": "enables", "term": "cholesterol transfer activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0120020", "pubmed": 1935934, "qualifier": "enables", "term": "cholesterol transfer activity"}]}, "homologene": {"genes": [[7955, 322543], [7955, 550608], [7955, 570354], [7955, 100004607], [7955, 100005908], [8364, 493461], [9031, 395780], [9544, 702424], [9598, 466792], [9606, 337], [9615, 489392], [9913, 537301], [10090, 11808], [10116, 25080]], "id": 47927}, "interpro": {"desc": "Apolipoprotein A/E", "id": "IPR000074", "short_desc": "ApoA_E"}, "map_location": "11q23.3", "name": "apolipoprotein A4", "other_names": ["apo-AIV", "apoA-IV", "apolipoprotein A-IV"], "pantherdb": {"HGNC": "602", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "88051", "ortholog_type": "LDO", "panther_family": "PTHR18976", "taxid": 10090, "uniprot_kb": "P06728"}, {"Ensembl": "ENSRNOG00000056851", "ortholog_type": "O", "panther_family": "PTHR18976", "taxid": 10116, "uniprot_kb": "A0A0G2K6J8"}, {"RGD": "2132", "ortholog_type": "LDO", "panther_family": "PTHR18976", "taxid": 10116, "uniprot_kb": "P02651"}, {"Ensembl": "ENSGALG00000007109", "ortholog_type": "LDO", "panther_family": "PTHR18976", "taxid": 9031, "uniprot_kb": "A0A3Q2UAF0"}, {"ZFIN": "ZDB-GENE-070410-86", "ortholog_type": "O", "panther_family": "PTHR18976", "taxid": 7955, "uniprot_kb": "F2Z4W5"}, {"ZFIN": "ZDB-GENE-050417-469", "ortholog_type": "LDO", "panther_family": "PTHR18976", "taxid": 7955, "uniprot_kb": "A0A0R4IU48"}, {"ZFIN": "ZDB-GENE-030131-1263", "ortholog_type": "O", "panther_family": "PTHR18976", "taxid": 7955, "uniprot_kb": "F1QHR0"}, {"ZFIN": "ZDB-GENE-030131-3143", "ortholog_type": "O", "panther_family": "PTHR18976", "taxid": 7955, "uniprot_kb": "B3DHC5"}, {"TAIR": "2047107", "ortholog_type": "O", "panther_family": "PTHR18976", "taxid": 3702, "uniprot_kb": "F4IFM3"}], "uniprot_kb": "P06727"}, "pathway": {"kegg": [{"id": "hsa04975", "name": "Fat digestion and absorption - Homo sapiens (human)"}, {"id": "hsa04977", "name": "Vitamin digestion and absorption - Homo sapiens (human)"}, {"id": "hsa04979", "name": "Cholesterol metabolism - Homo sapiens (human)"}, {"id": "hsa05417", "name": "Lipid and atherosclerosis - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-174824", "name": "Plasma lipoprotein assembly, remodeling, and clearance"}, {"id": "R-HSA-174824", "name": "Plasma lipoprotein assembly, remodeling, and clearance"}, {"id": "R-HSA-196854", "name": "Metabolism of vitamins and cofactors"}, {"id": "R-HSA-196854", "name": "Metabolism of vitamins and cofactors"}, {"id": "R-HSA-2187338", "name": "Visual phototransduction"}, {"id": "R-HSA-2187338", "name": "Visual phototransduction"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-6806667", "name": "Metabolism of fat-soluble vitamins"}, {"id": "R-HSA-6806667", "name": "Metabolism of fat-soluble vitamins"}, {"id": "R-HSA-8963888", "name": "Chylomicron assembly"}, {"id": "R-HSA-8963889", "name": "Assembly of active LPL and LIPC lipase complexes"}, {"id": "R-HSA-8963898", "name": "Plasma lipoprotein assembly"}, {"id": "R-HSA-8963899", "name": "Plasma lipoprotein remodeling"}, {"id": "R-HSA-8963899", "name": "Plasma lipoprotein remodeling"}, {"id": "R-HSA-8963901", "name": "Chylomicron remodeling"}, {"id": "R-HSA-9709957", "name": "Sensory Perception"}, {"id": "R-HSA-9709957", "name": "Sensory Perception"}, {"id": "R-HSA-975634", "name": "Retinoid metabolism and transport"}, {"id": "R-HSA-975634", "name": "Retinoid metabolism and transport"}, {"id": "R-HSA-977225", "name": "Amyloid fiber formation"}], "wikipathways": {"id": "WP430", "name": "Statin inhibition of cholesterol production"}}, "pdb": "3S84", "pfam": "PF01442", "pharmgkb": "PA24887", "pharos": {"target_id": 17507, "tdl": "Tbio"}, "pir": "A94137", "reagent": {"CM-LibrX-no-seq": [{"id": "GNF325262", "relationship": "is"}, {"id": "GNF325263", "relationship": "is"}, {"id": "GNF325264", "relationship": "is"}], "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167295", "relationship": "is"}, {"id": "GNF178201", "relationship": "is"}, {"id": "GNF189107", "relationship": "is"}, {"id": "GNF200013", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF278297", "relationship": "is"}, "MasterSecretomicsList": [{"id": "GNF330737", "relationship": "is"}, {"id": "GNF331992", "relationship": "is"}, {"id": "GNF333959", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF336118", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF095733", "relationship": "is"}, {"id": "GNF135389", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1", "NG_012044.1"], "protein": "NP_000473.2", "rna": "NM_000482.4", "translation": {"protein": "NP_000473.2", "rna": "NM_000482.4"}}, "reporter": {"HG-U133_Plus_2": "206894_at", "HG-U95Av2": "34523_at", "HTA-2_0": "TC11002327.hg.1", "HuEx-1_0": "3392973", "HuGene-1_1": ["7951859", "8077192"], "HuGene-2_1": "16744717"}, "summary": "Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon.  The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles.  Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro. [provided by RefSeq, Jul 2008].", "symbol": "APOA4", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412470"}, "unigene": "Hs.1247", "uniprot": {"Swiss-Prot": "P06727"}, "wikipedia": {"url_stub": "APOA4"}}